Company filings profile · CIK 0001585608
Jaguar Health, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Jaguar Health, Inc. (JAGX): 26 filings in the last 90 days vs 28 in the prior 90 (filing-velocity steady · 0.93×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.
Material 8-K events — Jaguar Health, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 24, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 21, 2026 | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 4, 2026 | Other Events | ↗ |
| Aug 19, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 1, 2026 | Other Events | ↗ |
| Jun 25, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 22, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 11, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jun 8, 2026 | Item 5.07; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| May 27, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
Watch Jaguar Health, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| Mar 12, 2026 | 4 | ↗ |
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 24, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 21, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 18, 2026 | PRE 14A | PRE 14A | ↗ |
| Sep 15, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 4, 2026 | 8-K | Other Events | ↗ |
| Sep 3, 2026 | 424B5 | 424B5 | ↗ |
| Aug 21, 2026 | 424B3 | 424B3 | ↗ |
| Aug 19, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 19, 2026 | 10-Q | 10-Q | ↗ |
| Aug 14, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Aug 14, 2026 | NT 10-Q | NT 10-Q | ↗ |
| Aug 11, 2026 | POS AM | POS AM | ↗ |
| Aug 3, 2026 | DEF 14A | DEF 14A | ↗ |
| Jul 27, 2026 | 424B3 | 424B3 | ↗ |
| Jul 27, 2026 | 424B3 | 424B3 | ↗ |
| Jul 24, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 24, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 24, 2026 | PRE 14A | PRE 14A | ↗ |
| Jul 24, 2026 | S-1/A | S-1/A | ↗ |
| Jul 16, 2026 | S-1 | S-1 | ↗ |
| Jul 16, 2026 | S-1 | S-1 | ↗ |
| Jul 14, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 1, 2026 | 8-K | Other Events | ↗ |
| Jul 1, 2026 | D | Item 06b | ↗ |
| Jul 1, 2026 | D | Item 06b | ↗ |
| Jun 25, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 22, 2026 | 8-K/A | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 22, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 11, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jun 8, 2026 | 8-K | Item 5.07; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | DEFA14A | DEFA14A | ↗ |
| May 27, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| May 22, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| May 20, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 20, 2026 | 10-Q | 10-Q | ↗ |
| May 19, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| May 18, 2026 | NT 10-Q | NT 10-Q | ↗ |